Find clinical trials for medical research studies worldwide.
Can CT scans help detect pancreatic cancer early in people recently diagnosed with diabetes? A pilot study to find out.
Status: Recruiting — Phase: Not Applicable — Start:
Conditions: Diabetes mellitus, Pancreatic cancer
View Study Details →Using artificial intelligence to track organ movement during radiotherapy for upper abdominal cancers
Status: Recruiting — Phase: — Start:
Conditions: Abdominal cancers, Pancreatic cancer, Liver cancer, Kidney cancer, Adrenal gland cancer
View Study Details →A study comparing a new drug combination (atebimetinib plus chemotherapy) versus standard chemotherapy alone as first treatment for advanced pancreatic cancer
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic, Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Adenocarcinoma
View Study Details →A study comparing a new cancer drug called daraxonrasib, alone or with standard chemotherapy, versus standard chemotherapy alone for people with advanced pancreatic cancer
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Adenocarcinoma Metastatic, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma
View Study Details →High-dose radiotherapy to treat multiple cancer sites in patients with advanced cancer who cannot receive chemotherapy
Status: Recruiting — Phase: Not Applicable — Start:
Conditions: metastatic cancer, metastatic malignancy, oesophageal cancer, pancreatic cancer, head and neck cancer, cutaneous squamous cell carcinoma, colorectal cancer, bladder cancer, triple-negative breast cancer, non-small cell lung cancer, skin cancer
View Study Details →A clinical trial to evaluate the safety and effectiveness of a new drug called kesonotide in treating solid tumors
Status: Recruiting — Phase: Phase 1,Phase 2 — Start:
Conditions: Prostate Cancers, Breast Cancer, Lung Cancers, Ovarian Cancer, Glioblastoma Multiforme (GBM), Pancreas Cancer, Skin Cancer
View Study Details →An early study to evaluate the safety and preliminary effects of a new cancer treatment called IDOV-Immune in people with advanced solid tumors
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: Colorectal Cancer, Pancreatic Cancer, Melanoma, Ovarian Cancer, Gastric Cancer, Esophageal Cancer, Hepatocellular Carcinoma, Renal Cell Carcinoma, Breast Cancer, Sarcoma, Bladder Cancer, Lung Cancer, Prostate Cancer, Cervical Cancers, Head and Neck Cancers, Adrenal Gland Tumors
View Study Details →A Study to Test the Safety and Effectiveness of an Investigational Drug (DM002) in Patients with Advanced Solid Tumors
Status: Recruiting — Phase: Phase 1,Phase 2 — Start:
Conditions: Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms, Colorectal Neoplasms, Solid Carcinoma, Pancreatic Cancer
View Study Details →A Study of an Experimental Drug (PTM-101) Combined with Chemotherapy in Patients with Pancreatic Cancer
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: Pancreatic Ductal Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer
View Study Details →Identifying Genetic Markers for Pancreatic Cancer Risk in Children with Pancreatitis
Status: Recruiting — Phase: — Start:
Conditions: Chronic Pancreatitis, Exocrine Pancreas Carcinoma, Recurrent Acute Pancreatitis
View Study Details →Improving Surgical Outcomes with Online Education and Exercise Programs
Status: Recruiting — Phase: Not Applicable — Start:
Conditions: Adults Waiting to Undergo Lung Cancer or Major Abdominal, Open or Video Assisted Cancer Surgery
View Study Details →A first-in-human study to evaluate the safety and effectiveness of a new investigational drug called ADCE-T02 in patients with advanced solid tumors
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: Advanced Solid Tumor, PDAC, HNSCC
View Study Details →Evaluating a Supportive Care Navigation Tool for People with Pancreatic Cancer
Status: Not Yet Recruiting — Phase: Not Applicable — Start:
Conditions: pancreatic cancer, unmet needs, survival
View Study Details →Specialist nurse-led telehealth symptom management for pancreatic cancer patients
Status: Recruiting — Phase: Not Applicable — Start:
Conditions: Pancreatic cancer
View Study Details →A Phase 1 study to evaluate the safety of a new investigational drug called ERX-315 in patients with advanced solid tumors
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: Advanced Solid Tumor, Metastatic Breast Cancer, Metastatic Ovarian Cancer, Metastatic Endometrial Cancer, Metastatic Liver Cancer, Metastatic Pancreatic Cancer
View Study Details →A study evaluating the safety and effectiveness of an investigational drug, LY4052031, in patients with advanced or metastatic solid tumors
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm, Triple Negative Breast Cancer, Non-small Cell Lung Cancer, Esophageal Cancer, Pancreatic Cancer, Ovarian Cancer, Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Prostate Cancer, Renal Pelvis Cancer, Bladder Cancer
View Study Details →Comparing finger prick and blood testing for measuring 5-fluorouracil drug levels in cancer patients
Status: Not Yet Recruiting — Phase: — Start:
Conditions: Colorectal cancer, Pancreatic cancer, Gastro-oesophageal cancer
View Study Details →A Phase 1 study evaluating the safety and effectiveness of an investigational drug, LY4170156, in treating advanced solid tumors
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: Ovarian Neoplasms, Endometrial Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Non-Small-Cell Lung, Triple Negative Breast Neoplasms, Pancreatic Neoplasm, Colorectal Neoplasms
View Study Details →Safety and efficacy of faecal transplant and chemotherapy in the management of pancreatic cancer
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: non-resectable pancreatic cancer
View Study Details →Evaluating the Effects of Stopping Somatostatin Analogues After Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors
Status: Recruiting — Phase: Phase 2 — Start:
Conditions: Neuroendocrine Tumors
View Study Details →